These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35741068)

  • 41. Clinical and genetic aspects of PCDH19-related epilepsy syndromes and the possible role of PCDH19 mutations in males with autism spectrum disorders.
    van Harssel JJ; Weckhuysen S; van Kempen MJ; Hardies K; Verbeek NE; de Kovel CG; Gunning WB; van Daalen E; de Jonge MV; Jansen AC; Vermeulen RJ; Arts WF; Verhelst H; Fogarasi A; de Rijk-van Andel JF; Kelemen A; Lindhout D; De Jonghe P; Koeleman BP; Suls A; Brilstra EH
    Neurogenetics; 2013 Feb; 14(1):23-34. PubMed ID: 23334464
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of seizure susceptibility in Pcdh19 mice.
    Rakotomamonjy J; Sabetfakhri NP; McDermott SL; Guemez-Gamboa A
    Epilepsia; 2020 Oct; 61(10):2313-2320. PubMed ID: 32944953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epilepsy and mental retardation limited to females with PCDH19 mutations can present de novo or in single generation families.
    Hynes K; Tarpey P; Dibbens LM; Bayly MA; Berkovic SF; Smith R; Raisi ZA; Turner SJ; Brown NJ; Desai TD; Haan E; Turner G; Christodoulou J; Leonard H; Gill D; Stratton MR; Gecz J; Scheffer IE
    J Med Genet; 2010 Mar; 47(3):211-6. PubMed ID: 19752159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expanding the genetic and clinical characteristics of Protocadherin 19 gene mutations.
    Dell'Isola GB; Mencaroni E; Fattorusso A; Tascini G; Prontera P; Imperatore V; Di Cara G; Striano P; Verrotti A
    BMC Med Genomics; 2022 Aug; 15(1):181. PubMed ID: 35978409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mapping combinatorial expression of non-clustered protocadherins in the developing brain identifies novel PCDH19-mediated cell adhesion properties.
    Mincheva-Tasheva S; Pfitzner C; Kumar R; Kurtsdotter I; Scherer M; Ritchie T; Muhr J; Gecz J; Thomas PQ
    Open Biol; 2024 Apr; 14(4):230383. PubMed ID: 38629124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pcdh19 Loss-of-Function Increases Neuronal Migration In Vitro but is Dispensable for Brain Development in Mice.
    Pederick DT; Homan CC; Jaehne EJ; Piltz SG; Haines BP; Baune BT; Jolly LA; Hughes JN; Gecz J; Thomas PQ
    Sci Rep; 2016 May; 6():26765. PubMed ID: 27240640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A complete Protocadherin-19 ectodomain model for evaluating epilepsy-causing mutations and potential protein interaction sites.
    Hudson JD; Tamilselvan E; Sotomayor M; Cooper SR
    Structure; 2021 Oct; 29(10):1128-1143.e4. PubMed ID: 34520737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment.
    Dibbens LM; Tarpey PS; Hynes K; Bayly MA; Scheffer IE; Smith R; Bomar J; Sutton E; Vandeleur L; Shoubridge C; Edkins S; Turner SJ; Stevens C; O'Meara S; Tofts C; Barthorpe S; Buck G; Cole J; Halliday K; Jones D; Lee R; Madison M; Mironenko T; Varian J; West S; Widaa S; Wray P; Teague J; Dicks E; Butler A; Menzies A; Jenkinson A; Shepherd R; Gusella JF; Afawi Z; Mazarib A; Neufeld MY; Kivity S; Lev D; Lerman-Sagie T; Korczyn AD; Derry CP; Sutherland GR; Friend K; Shaw M; Corbett M; Kim HG; Geschwind DH; Thomas P; Haan E; Ryan S; McKee S; Berkovic SF; Futreal PA; Stratton MR; Mulley JC; Gécz J
    Nat Genet; 2008 Jun; 40(6):776-81. PubMed ID: 18469813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recurrence risk of epilepsy and mental retardation in females due to parental mosaicism of PCDH19 mutations.
    Dibbens LM; Kneen R; Bayly MA; Heron SE; Arsov T; Damiano JA; Desai T; Gibbs J; McKenzie F; Mulley JC; Ronan A; Scheffer IE
    Neurology; 2011 Apr; 76(17):1514-9. PubMed ID: 21519002
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiomic analysis implicates nuclear hormone receptor signalling in clustering epilepsy.
    de Nys R; van Eyk CL; Ritchie T; Møller RS; Scheffer IE; Marini C; Bhattacharjee R; Kumar R; Gecz J
    Transl Psychiatry; 2024 Jan; 14(1):65. PubMed ID: 38280856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Somatic mosaicism of PCDH19 mutation in a family with low-penetrance EFMR.
    Terracciano A; Specchio N; Darra F; Sferra A; Bernardina BD; Vigevano F; Bertini E
    Neurogenetics; 2012 Nov; 13(4):341-5. PubMed ID: 22949144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characteristic phasic evolution of convulsive seizure in PCDH19-related epilepsy.
    Ikeda H; Imai K; Ikeda H; Shigematsu H; Takahashi Y; Inoue Y; Higurashi N; Hirose S
    Epileptic Disord; 2016 Mar; 18(1):26-33. PubMed ID: 26898795
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Focal cortical malformations in children with early infantile epilepsy and PCDH19 mutations: case report.
    Kurian M; Korff CM; Ranza E; Bernasconi A; Lübbig A; Nangia S; Ramelli GP; Wohlrab G; Nordli DR; Bast T
    Dev Med Child Neurol; 2018 Jan; 60(1):100-105. PubMed ID: 29064093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PCDH19-related female-limited epilepsy: further details regarding early clinical features and therapeutic efficacy.
    Higurashi N; Nakamura M; Sugai M; Ohfu M; Sakauchi M; Sugawara Y; Nakamura K; Kato M; Usui D; Mogami Y; Fujiwara Y; Ito T; Ikeda H; Imai K; Takahashi Y; Nukui M; Inoue T; Okazaki S; Kirino T; Tomonoh Y; Inoue T; Takano K; Shimakawa S; Hirose S
    Epilepsy Res; 2013 Sep; 106(1-2):191-9. PubMed ID: 23712037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cellular and Behavioral Characterization of
    Galindo-Riera N; Newbold SA; Sledziowska M; Llinares-Benadero C; Griffiths J; Mire E; Martinez-Garay I
    eNeuro; 2021; 8(4):. PubMed ID: 34272258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PCDH19 mutations in female patients from Southern Italy.
    Gagliardi M; Annesi G; Sesta M; Tarantino P; Conti P; Labate A; Di Rosa G; Quattrone A; Gambardella A
    Seizure; 2015 Jan; 24():118-20. PubMed ID: 25218114
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Epilepsy-Related Protein PCDH19 Regulates Tonic Inhibition, GABA
    Serratto GM; Pizzi E; Murru L; Mazzoleni S; Pelucchi S; Marcello E; Mazzanti M; Passafaro M; Bassani S
    Mol Neurobiol; 2020 Dec; 57(12):5336-5351. PubMed ID: 32880860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epilepsy surgery as a treatment option for select patients with PCDH19-related epilepsy.
    Simmons R; Singhal N; Sullivan J; Shih T; Tihan T; Poduri A; Smith L; Yang E
    Epilepsy Behav; 2023 Dec; 149():109517. PubMed ID: 37956604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A systematic review and meta-analysis of 271 PCDH19-variant individuals identifies psychiatric comorbidities, and association of seizure onset and disease severity.
    Kolc KL; Sadleir LG; Scheffer IE; Ivancevic A; Roberts R; Pham DH; Gecz J
    Mol Psychiatry; 2019 Feb; 24(2):241-251. PubMed ID: 29892053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations of protocadherin 19 in female epilepsy (PCDH19-FE) lead to allopregnanolone deficiency.
    Tan C; Shard C; Ranieri E; Hynes K; Pham DH; Leach D; Buchanan G; Corbett M; Shoubridge C; Kumar R; Douglas E; Nguyen LS; Mcmahon J; Sadleir L; Specchio N; Marini C; Guerrini R; Moller RS; Depienne C; Haan E; Thomas PQ; Berkovic SF; Scheffer IE; Gecz J
    Hum Mol Genet; 2015 Sep; 24(18):5250-9. PubMed ID: 26123493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.